Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dhbuzz Member Profile
 
Followed By 9
Posts 2,744
Boards Moderated 0
Alias Born 03/01/19
160x600 placeholder
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the 2020 Virtual Annual Meeting of the American Epilepsy S... GlobeNewswire Inc. - 11/23/2020 11:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 7:17:39 AM
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights GlobeNewswire Inc. - 11/9/2020 6:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2020 4:16:27 PM
Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the... GlobeNewswire Inc. - 10/15/2020 3:06:10 PM
New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder... GlobeNewswire Inc. - 10/15/2020 3:05:10 PM
Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACA... GlobeNewswire Inc. - 10/8/2020 8:32:10 AM
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Virtual Joint 49th Annual Child Neurology Society & 16... GlobeNewswire Inc. - 10/8/2020 8:30:10 AM
Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome GlobeNewswire Inc. - 9/17/2020 1:55:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 7:02:02 AM
Zynerba Pharmaceuticals Provides Update on Recent Milestones GlobeNewswire Inc. - 9/14/2020 6:55:10 AM
Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences GlobeNewswire Inc. - 9/10/2020 7:30:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 9:28:55 AM
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights GlobeNewswire Inc. - 8/10/2020 6:45:10 AM
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference GlobeNewswire Inc. - 8/6/2020 7:00:10 AM
Zynerba Pharmaceuticals to Present an Update on the Zygel™ Development Program at the 17th NFXF International Fragile X Con... GlobeNewswire Inc. - 7/22/2020 6:50:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/10/2020 10:43:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2020 6:59:54 AM
Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome... GlobeNewswire Inc. - 6/30/2020 6:45:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 5:43:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 5:41:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 5:39:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 5:37:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 5:34:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 5:31:25 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences